Trial NCT02750930

View at ClinicalTrials.gov 
Org. Study IDs: 204682

Last trial update was posted on 2019-07-12

MeSH Interventions

rGLP-1 protein

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions


Stopping Reasons

The termination was result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID